False-positive elevation of 1,3-beta-D-glucan caused by continuous administration of penicillin G

被引:13
|
作者
Ito, Shoko [1 ]
Ashizawa, Masahiro [1 ]
Sasaki, Ryo [2 ]
Ikeda, Takashi [1 ]
Toda, Yumiko [1 ]
Mashima, Kiyomi [1 ]
Umino, Kento [1 ]
Minakata, Daisuke [1 ]
Nakano, Hirofumi [1 ]
Yamasaki, Ryoko [1 ]
Kawasaki, Yasufumi [1 ]
Sugimoto, Miyuki [1 ]
Yamamoto, Chihiro [1 ]
Fujiwara, Shin-ichiro [1 ]
Hatano, Kaoru [1 ]
Sato, Kazuya [1 ]
Oh, Iekuni [1 ]
Ohmine, Ken [1 ]
Muroi, Kazuo [1 ]
Suzuki, Jun [3 ]
Hatakeyama, Shuji [2 ,3 ]
Morisawa, Yuji [3 ]
Yamada, Toshiyuki [4 ]
Kanda, Yoshinobu [1 ]
机构
[1] Jichi Med Univ Hosp, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan
[2] Jichi Med Univ Hosp, Div Gen Internal Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan
[3] Jichi Med Univ Hosp, Div Infect Dis, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan
[4] Jichi Med Univ Hosp, Dept Clin Lab Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan
关键词
1,3-Beta-D-Glucan; False positive; Penicillin G; INVASIVE FUNGAL-INFECTIONS; BETA-D-GLUCAN; HEMATOLOGICAL MALIGNANCIES; DIAGNOSIS; ANTIMICROBIALS; GALACTOMANNAN; COMPONENTS; DISEASE; ASSAY;
D O I
10.1016/j.jiac.2018.06.008
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The 1,3-beta-D-Glucan (BDG) assay is widely used for the diagnosis of fungal infections, especially in patients with hematologic malignancies. Some antimicrobials have been reported to cause false-positive results for BDG, but there has been no report on the effect of penicillin G (PCG) on BDG levels. We experienced a patient who developed false-positive BDG elevation during the administration of PCG for osteomyelitis due to Streptococcus pneumoniae infection. The serum BDG level increased up to 81.0 pg/ml during the continuous administration of PCG at 24 million units per day. However, chest and paranasal CT scan showed no evidence of fungal infection. The BDG level decreased to 38.0 pg/ml at 14 hours after the discontinuation of PCG. The amount of BDG in one vial of PCG inferred from these serum BDG levels is very similar to the actual BDG concentration in a vial of PCG. Therefore, during the administration of PCG, elevated BDG levels should be interpreted with caution, as they may be false-positive results. (C) 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:812 / 814
页数:3
相关论文
共 50 条
  • [31] Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation
    Reischies, F. M. J.
    Prattes, J.
    Woelfler, A.
    Eigl, S.
    Hoenigl, M.
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (03) : 466 - 470
  • [32] CHARACTERIZATION OF 1,3-BETA-D-GLUCAN (CALLOSE) SYNTHESIS IN ROOTS OF TRITICUM-AESTIVUM IN RESPONSE TO ALUMINUM TOXICITY
    ZHANG, GC
    HODDINOTT, J
    TAYLOR, GJ
    JOURNAL OF PLANT PHYSIOLOGY, 1994, 144 (02) : 229 - 234
  • [33] High False-Positive Rate of (1,3)-β-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies
    Tschopp, Jonathan
    Brunel, Anne-Sophie
    Spertini, Olivier
    Croxatto, Anthony
    Lamoth, Frederic
    Bochud, Pierre-Yves
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (02) : 330 - 333
  • [34] In vitro activity of 1,3-beta-D-glucan synthase requires the GTP-binding protein Rho1
    Mazur, P
    Baginsky, W
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) : 14604 - 14609
  • [35] Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease
    Katia Farias e Silva
    Hayandra F Nanini
    Cynthia Machado Cascabulho
    Siane L B Rosas
    Patricia T Santana
    Antonio José de V Carneiro
    Elias Anaissie
    Marcio Nucci
    Heitor Siffert Pereira de Souza
    World Journal of Gastroenterology, 2021, 27 (09) : 866 - 885
  • [36] Reliability of serum 1,3-beta-D-glucan assay in patients undergoing renal replacement therapy: a review of the literature
    Prattes, Juergen
    Schilcher, Gernot
    Krause, Robert
    MYCOSES, 2015, 58 (01) : 4 - 9
  • [37] Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors
    Douglas, CM
    DIppolito, JA
    Shei, GJ
    Meinz, M
    Onishi, J
    Marrinan, JA
    Li, W
    Abruzzo, GK
    Flattery, A
    Bartizal, K
    Mitchell, A
    Kurtz, MB
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2471 - 2479
  • [38] Diagnostic performance of 1,3-beta-d-glucan Serum Screening in Patients receiving Hematolopoietic Stem Cell Transplantation
    Reischies, F. M.
    Prattes, J.
    Eigl, S.
    List, A.
    Raggam, R. B.
    Zollner-Schwetz, I.
    Valentin, T.
    Flick, H.
    Woelfler, A.
    Prueller, F.
    Krause, R.
    Hoenigl, M.
    MYCOSES, 2015, 58 : 159 - 159
  • [39] Challenges with Utilizing the 1,3-Beta-D-Glucan and Galactomannan Assays To Diagnose Invasive Mold Infections in Immunocompromised Children
    Hsu, Alice J.
    Tamma, Pranita D.
    Zhang, Sean X.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (09)
  • [40] Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease
    Farias e Silva, Katia
    Nanini, Hayandra F.
    Cascabulho, Cynthia Machado
    Rosas, Siane L. B.
    Santana, Patricia T.
    Carneiro, Antonio Jose de, V
    Anaissie, Elias
    Nucci, Marcio
    de Souza, Heitor Siffert Pereira
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (09) : 866 - 885